GlassScriptPhysician profile
Rohit Gautam
NPI 1780994194
$1,406.27
in general payments reported to CMS, 2019-2025
18 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2021: $28.85 · 2022: $213 · 2023: $489 · 2024: $349 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,046.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $370.82 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $184.75 | 2019-2024 | Verquvo |
| Pfizer INC. | $128.18 | 2021-2024 | |
| Exact Sciences Corporation | $113.01 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $112.12 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $91.79 | 2019-2024 | Jardiance, Emgality, Synjardy |
| Novo Nordisk INC | $86.58 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Scilex Pharmaceuticals INC. | $55.93 | 2022-2023 | Ztlido |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.59 | 2023-2025 | Jascayd, Jardiance, Tradjenta |
| Abbott Laboratories | $36.02 | 2024 | Freestyle Libre 3, Mitraclip |
| Glaxosmithkline, LLC. | $35.55 | 2019-2024 | Trelegy Ellipta |
| Almatica Pharma LLC | $28.29 | 2025 | Teriparatide |
| Corium, LLC | $27.94 | 2025 | Azstarys |
| Cmp Pharma, INC. | $21.15 | 2023 | Norliqva, Carospir, Tadliq |
| Janssen Pharmaceuticals, INC | $18.60 | 2023 | Xarelto |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $18.03 | 2024 | Dexcom G6 Transmitter |
| Edwards Lifesciences Corporation | $17.07 | 2023 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Gautam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.